BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 19164809)

  • 1. ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cells.
    Parks BW; Srivastava R; Yu S; Kabarowski JH
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):539-47. PubMed ID: 19164809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice.
    Parks BW; Lusis AJ; Kabarowski JH
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2703-9. PubMed ID: 16990555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid cell-specific ATP-binding cassette transporter A1 deletion has minimal impact on atherogenesis in atherogenic diet-fed low-density lipoprotein receptor knockout mice.
    Bi X; Zhu X; Gao C; Shewale S; Cao Q; Liu M; Boudyguina E; Gebre AK; Wilson MD; Brown AL; Parks JS
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1888-99. PubMed ID: 24833800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency.
    Wang M; Subramanian M; Abramowicz S; Murphy AJ; Gonen A; Witztum J; Welch C; Tabas I; Westerterp M; Tall AR
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):976-84. PubMed ID: 24651678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ApoE suppresses atherosclerosis by reducing lipid accumulation in circulating monocytes and the expression of inflammatory molecules on monocytes and vascular endothelium.
    Gaudreault N; Kumar N; Posada JM; Stephens KB; Reyes de Mochel NS; Eberlé D; Olivas VR; Kim RY; Harms MJ; Johnson S; Messina LM; Rapp JH; Raffai RL
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):264-72. PubMed ID: 22053073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased atherosclerosis in low-density lipoprotein receptor knockout mice transplanted with Abcg1-/- bone marrow.
    Ranalletta M; Wang N; Han S; Yvan-Charvet L; Welch C; Tall AR
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2308-15. PubMed ID: 16917103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G2A deficiency in mice promotes macrophage activation and atherosclerosis.
    Bolick DT; Skaflen MD; Johnson LE; Kwon SC; Howatt D; Daugherty A; Ravichandran KS; Hedrick CC
    Circ Res; 2009 Feb; 104(3):318-27. PubMed ID: 19106413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression. A new SREBP1-dependent mechanism.
    Zhou X; He W; Huang Z; Gotto AM; Hajjar DP; Han J
    J Biol Chem; 2008 Jan; 283(4):2129-38. PubMed ID: 18029360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein receptor-related protein 1 prevents early atherosclerosis by limiting lesional apoptosis and inflammatory Ly-6Chigh monocytosis: evidence that the effects are not apolipoprotein E dependent.
    Yancey PG; Ding Y; Fan D; Blakemore JL; Zhang Y; Ding L; Zhang J; Linton MF; Fazio S
    Circulation; 2011 Jul; 124(4):454-64. PubMed ID: 21730304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis.
    Bi X; Zhu X; Duong M; Boudyguina EY; Wilson MD; Gebre AK; Parks JS
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2288-96. PubMed ID: 23814116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmented atherogenesis in LDL receptor deficient mice lacking both macrophage ABCA1 and ApoE.
    Lammers B; Zhao Y; Hoekstra M; Hildebrand RB; Ye D; Meurs I; Van Berkel TJ; Van Eck M
    PLoS One; 2011; 6(10):e26095. PubMed ID: 22022523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial lipase modulates HDL but has no effect on atherosclerosis development in apoE-/- and LDLR-/- mice.
    Ko KW; Paul A; Ma K; Li L; Chan L
    J Lipid Res; 2005 Dec; 46(12):2586-94. PubMed ID: 16199802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific roles of ABCA1 influence susceptibility to atherosclerosis.
    Brunham LR; Singaraja RR; Duong M; Timmins JM; Fievet C; Bissada N; Kang MH; Samra A; Fruchart JC; McManus B; Staels B; Parks JS; Hayden MR
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):548-54. PubMed ID: 19201688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein AI and high-density lipoprotein have anti-inflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette A-1, ATP-binding cassette G-1, and scavenger receptor B-1.
    Umemoto T; Han CY; Mitra P; Averill MM; Tang C; Goodspeed L; Omer M; Subramanian S; Wang S; Den Hartigh LJ; Wei H; Kim EJ; Kim J; O'Brien KD; Chait A
    Circ Res; 2013 May; 112(10):1345-54. PubMed ID: 23501697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.
    Zhang W; Yancey PG; Su YR; Babaev VR; Zhang Y; Fazio S; Linton MF
    Circulation; 2003 Nov; 108(18):2258-63. PubMed ID: 14581413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired development of atherosclerosis in hyperlipidemic Ldlr-/- and ApoE-/- mice transplanted with Abcg1-/- bone marrow.
    Baldán A; Pei L; Lee R; Tarr P; Tangirala RK; Weinstein MM; Frank J; Li AC; Tontonoz P; Edwards PA
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2301-7. PubMed ID: 16888235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased atherosclerosis in P2Y13/apolipoprotein E double-knockout mice: contribution of P2Y13 to reverse cholesterol transport.
    Lichtenstein L; Serhan N; Espinosa-Delgado S; Fabre A; Annema W; Tietge UJ; Robaye B; Boeynaems JM; Laffargue M; Perret B; Martinez LO
    Cardiovasc Res; 2015 May; 106(2):314-23. PubMed ID: 25770145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.
    Valenta DT; Ogier N; Bradshaw G; Black AS; Bonnet DJ; Lagrost L; Curtiss LK; Desrumaux CM
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1572-8. PubMed ID: 16675720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-/- mice.
    Horie T; Baba O; Kuwabara Y; Chujo Y; Watanabe S; Kinoshita M; Horiguchi M; Nakamura T; Chonabayashi K; Hishizawa M; Hasegawa K; Kume N; Yokode M; Kita T; Kimura T; Ono K
    J Am Heart Assoc; 2012 Dec; 1(6):e003376. PubMed ID: 23316322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of bone marrow ATP-binding cassette transporter A1 deficiency on atherogenesis is independent of the presence of the low-density lipoprotein receptor.
    Ouweneel AB; Zhao Y; Calpe-Berdiel L; Lammers B; Hoekstra M; Van Berkel TJC; Van Eck M
    Atherosclerosis; 2021 Feb; 319():79-85. PubMed ID: 33494008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.